LY2955303 - CAS 1433497-19-8
Catalog number: 1433497-19-8
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
Molecular Weight:
LY2955303 is a selective Retinoic acid receptor gamma (RAR-γ) antagonist with Ki of 1.09 nM; (RAR-α Ki > 1700 nM; RAR-β Ki > 2980 nM). LY2955303 showed good pharmacokinetic properties and was efficacious in the MIA model of osteoarthritis-like joint pain. It can be used for the treatment of osteoarthritis pain.
LY2955303; LY-2955303; LY 2955303. 4-(5-(3,5-di-tert-butylphenyl)-1-(4-(4-methylpiperazine-1-carbonyl)phenyl)-1H-pyrazol-3-yl)benzoic acid
Soluble in DMSO
-20°C Freezer
osteoarthritis pain
Quality Standard:
In-house standard
Shelf Life:
2 month in rt, long time
Canonical SMILES:
1.Identification of potent and selective retinoic acid receptor gamma (RARγ) antagonists for the treatment of osteoarthritis pain using structure based drug design.
Hughes NE;Bleisch TJ;Jones SA;Richardson TI;Doti RA;Wang Y;Stout SL;Durst GL;Chambers MG;Oskins JL;Lin C;Adams LA;Page TJ;Barr RJ;Zink RW;Osborne H;Montrose-Rafizadeh C;Norman BH Bioorg Med Chem Lett. 2016 Jul 15;26(14):3274-3277. doi: 10.1016/j.bmcl.2016.05.056. Epub 2016 May 20.
A series of triaryl pyrazoles were identified as potent pan antagonists for the retinoic acid receptors (RARs) α, β and γ. X-ray crystallography and structure-based drug design were used to improve selectivity for RARγ by targeting residue differences in the ligand binding pockets of these receptors. This resulted in the discovery of novel antagonists which maintained RARγ potency but were greater than 500-fold selective versus RARα and RARβ. The potent and selective RARγ antagonist LY2955303 demonstrated good pharmacokinetic properties and was efficacious in the MIA model of osteoarthritis-like joint pain. This compound demonstrated an improved margin to RARα-mediated adverse effects.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related RAR/RXR Products

CAS 1190848-23-7 Fluorobexarotene

(CAS: 1190848-23-7)

Fluorobexarotene is a RXR agonist (Ki = 12 nM; EC50 = 43 nM at RXRα receptors).

CAS 71441-28-6 TTNPB

(CAS: 71441-28-6)

TTNPB potently and selectively activates retinoic acid receptors (EC50s = 21, 4, and 2.4 nM for RARα, RARβ, and RARγ, respectively). And it does not act on reti...

CAS 110368-33-7 Ch 55

Ch 55
(CAS: 110368-33-7)

Ch 55 is a highly potent synthetic analog of retinoic acid which is an effective inhibitor of angiogenesis. It has high affinity for RAR-α and RAR-β receptors, ...

CAS 859498-05-8 AGN 205728

AGN 205728
(CAS: 859498-05-8)

AGN 205728 is a potent and selective RARγ antagonist and has no inhibiton on RARα and RARβ.

CAS 188844-34-0 HX 531

HX 531
(CAS: 188844-34-0)

HX 531 is a potent RXR antagonist (IC50 = 18 nM) that inhibits 9-cis retinoic acid-induced transactivation of RXR. HX 531 promotes the differentiation of white ...

CAS 118292-40-3 Tazarotene

(CAS: 118292-40-3)

Tazarotene could propel either early or late portions of the period leading to differentiation and G0 arrest and is interchangeable with an RARalpha-selective l...

CAS 410528-02-8 Palovarotene

(CAS: 410528-02-8)

Palovarotene is a selective retinoic acid receptor gamma(RAR-γ) agonist for the treatment of emphysema. In small animal studies, palovarotene was claimed to rev...

CAS 102121-60-8 AM580

(CAS: 102121-60-8)

AM580 is a stable retinobenzoic derivative originally synthesized as a RARα agonist (EC50 values are 0.3, 8.6 and 13 nM for RARα, RARβ and RARγ respectively).

Quick Inquiry

Verification code

Featured Items